Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 0.993\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCOCCCNCc1cc(Br)ccc1OCC.Cl
b: CCCc1cc(NC(=O)COC(=O)c2nccnc2N)n(-c2ccccc2)n1
c: CC(=O)N1c2ccc(S(=O)(=O)NCCc3ccc(S(N)(=O)=O)cc3)cc2CC1C
Answer: b. CCCc1cc(NC(=O)COC(=O)c2nccnc2N)n(-c2ccccc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(NC(=O)COC(=O)c2nccnc2N)n(-c2ccccc2)n1
CCCc1cc(NC(=O)COC(=O)c2nccnc2N)n(-c2ccccc2)n1
[2-oxo-2-[(2-phenyl-5-propylpyrazol-3-yl)amino]ethyl] 3-aminopyrazine-2-carboxylate